InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Discover the complete record of transactions filed by Yang Allen, Chairman & CEO. Director active across 1 company, notably Xencor Inc. Aggregated, 4 reports have been published. Split: 0 buy · 3 sells. Total volume traded: €269k. Activity tracked since 17 December 2021. The latest transaction was disclosed on 9 March 2022 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
1,200 shares@ US$28.93620.0029% mcap11.9% of flowCommon StockSEC:0001415889-22-002841:0
33,174 shares0Common StockSEC:0001415889-22-002667:0
3,664 shares@ US$36.6205100.0% of flowCommon StockSEC:0001415889-21-006125
3,664 shares@ US$36.62050.011% mcap44.1% of flowCommon StockSEC:0001415889-21-006125:0
4 of 4 declarations
About Yang Allen
Yang Allen is the President and Chief Executive Officer of Xencor Inc. He oversees the strategic operations of the company, focusing on the development of innovative therapies. His leadership and vision are essential in guiding Xencor to new heights in the biopharmaceutical sector.
